Kairos Pharma, Ltd.
KAPA
$1.66
$0.000.00%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.39M | -1.65M | -1.37M | -1.40M | -1.42M |
| Total Depreciation and Amortization | 22.00K | 40.00K | 40.00K | 40.00K | 40.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 472.00K | 479.00K | 471.00K | 730.00K | 1.38M |
| Change in Net Operating Assets | -118.00K | 99.00K | -230.00K | -210.00K | -798.00K |
| Cash from Operations | -1.01M | -1.04M | -1.08M | -838.00K | -805.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 3.38M | 223.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.00K | 220.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -37.00K | 220.00K | 0.00 | 3.38M | 223.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.05M | -816.00K | -1.08M | 2.54M | -582.00K |